Atlas Oncology Partners

What Atlas Oncology Partners does

Atlas Oncology Partners is a Nashville-based, value-based oncology enablement platform founded in 2025 by healthcare investment firm Rubicon Founders. The company embeds interdisciplinary care teams — including providers, nurses, patient navigators, and social workers — into community oncology practices and layers in a health economics and analytics platform that unifies clinical, claims, and operational data sources into actionable insights. Its care model spans clinical evaluation, cancer-adjacent condition management, care coordination and psychosocial support, 24/7 symptom triage, and advanced supportive care delivered across all cancer types and stages.

Atlas assumes full medical cost risk from Medicare Advantage and Commercial payers and contracts with oncology practice partners on outcomes-based, total-cost-of-care arrangements, providing capital, technology, operational staffing, and contract negotiation as part of its provider services. Its two flagship go-lives are with West Cancer Center & Research Institute in Memphis (operational since January 2026) and Humana for Medicare Advantage members in Tennessee and Mississippi (effective January 2026). The company closed a $28 million Series A in February 2026 led by Flare Capital Partners with participation from Rubicon Founders, earmarked for Southeast US geographic expansion and clinical/operational infrastructure scaling.

Name

Atlas Oncology Partners

Legal name

Atlas Oncology Partners LLC

Website

https://atlasoncpartners.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Atlas Oncology Partners is a value-based oncology enablement platform that embeds interdisciplinary care teams into community oncology practices and assumes full medical cost risk from Medicare Advantage and Commercial payers across the Southeast US.

Ownership category

akta.pro rank

Product category

Value-Based Oncology Care Enablement

NAICS

Offices of Physicians (62111), Offices of All Other Health Practitioners (62139)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)

akta.pro secondary industries

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Value-Based Primary Care Organizations (Risk-Bearing) (HLAFAGAF)

Keywords

• Value-based oncology
• Cancer care enablement
• Oncology care management
• Medical cost risk
• Community oncology

Headquarters

HQ city

Nashville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Value-Based Care Contracts with Full Medical Cost Risk: Atlas generates revenue by assuming full medical cost risk from payers in exchange for managing coordinated, value-based oncology care. The company invests in clinical services, technology infrastructure, and operational staff, with financial returns tied to reducing avoidable costs and improving patient outcomes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Atlas Oncology Partners operates a value-based oncology enablement platform that embeds interdisciplinary care teams within community oncology practices and assumes full medical cost risk from Medicare Advantage and Commercial payers. The company delivers longitudinal, condition-based, total-cost-of-care cancer care through two integrated suites: an Extended Care Team providing patient services (clinical evaluation, cancer-adjacent condition management, care coordination, psychosocial support, symptom management, and advanced supportive care), and a Provider Services suite offering contracting, health economics and analytics, capital partnership, and care model enhancements to oncology practices.

Product overview

Atlas Oncology Partners operates as a value-based oncology enablement platform offering a unified portfolio of patient services and provider services. The Extended Care Team delivers embedded interdisciplinary patient support including clinical evaluation, cancer-adjacent condition management, care coordination, symptom management, and advanced supportive care. The Provider Services suite supports oncology practices with contracting, health economics and analytics, capital investment, and care model enhancements. Together, these components form an integrated model where Atlas assumes full medical cost risk from payers and aligns incentives with high-value network of medical oncology practice partners to deliver coordinated, value-based cancer care.

Differentiator

Problem solved

Functional benefit

Products and services

• Atlas Extended Care Team (Patient Services) Interdisciplinary care teams embedded within oncology practices delivering patient-centered supportive care services including clinical evaluation and documentation integrity, cancer-adjacent condition management, care coordination and psychosocial support, 24/7 symptom management triage, and advanced supportive care with goals-of-care clarification. Designed for oncology patients in active treatment and beyond across all cancer types and stages.
• Provider Services A suite of services for oncology practice partners including outcomes-based contracting across Medicare Advantage and Commercial lines of business, health economics and analytics with advanced data and actuarial expertise, capital partnership for technology and Extended Care Team investments, and locally managed care model enhancements. Designed for community oncology practices seeking to participate in value-based care without bearing full financial or administrative risk.
• Value-Based Oncology Enablement Platform An oncology enablement platform that embeds interdisciplinary care teams within community oncology practices, assumes full medical cost risk from Medicare Advantage and Commercial payers, and delivers coordinated, value-based cancer care through longitudinal, condition-based, total-cost-of-care value-based contracts. Designed for community oncology practices, at-risk primary care providers, and payers seeking aligned specialty care partnerships.

Quantifiable outcome

• High-quality, value-based care that reduces avoidable costs and eases the financial burden on patients

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• West Cancer Center & Research InstituteflagshipStrategic or Co-development Partner · 21 January 2026First operational partner site launched in Memphis, Tennessee. Atlas embeds interdisciplinary care teams within West Cancer Center to deliver coordinated, value-based cancer care, enhancing the patient experience and supporting oncology providers with additional resources.
• HumanacoreStrategic or Co-development Partner · 13 January 2026Partnership to provide integrated cancer care for Medicare Advantage members in Tennessee and Mississippi, effective January 1, 2026. Humana members have access to Atlas care model services including embedded holistic patient support, care coordination, and advanced supportive care to simplify and connect cancer care delivery.

Scale indicators2 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Privia Health: Privia Health is a physician enablement platform that supports practices with technology, payer contracting, and value-based care arrangements. It is comparable as a multi-specialty provider enablement platform with risk-bearing capabilities, though not oncology-focused.
• City of Hope: City of Hope (which acquired Cancer Treatment Centers of America) is a specialty oncology hospital and research enterprise with value-based and population health programs. It is comparable as a major specialty oncology provider with risk-bearing and care-coordination capabilities.
• Agilon Health: Agilon Health is a value-based care enablement company that partners with primary care physicians to assume full medical risk from Medicare Advantage plans. It is comparable to Atlas in its risk-bearing, payer-aligned, provider-partnership model, although focused on primary care rather than oncology.
• The US Oncology Network: The US Oncology Network, part of McKesson, is one of the largest networks of community oncology practices and provides value-based contracting, technology, and operational support. It is a broad incumbent analog to Atlas's enablement platform for community oncology practices.
• Astrana Health: Astrana Health (formerly Apollo Medical Holdings) is a value-based, risk-bearing care delivery and enablement platform serving Medicare and commercial populations. It is comparable to Atlas as a diversified risk-bearing platform with payer contracts and provider partnerships.
• Evolent Health: Evolent Health is a value-based care platform that partners with payers and providers across multiple specialties, including oncology, to manage total cost of care. It is comparable as a specialty and value-based care enablement incumbent with full or shared risk arrangements.

Emerging players

• Pearl Health: Pearl Health is an emerging value-based care enablement platform for primary care physicians taking risk from Medicare Advantage plans. It is comparable to Atlas as a tech-enabled, risk-bearing enablement platform for physician practices, though in primary care rather than oncology.
• Flatiron Health: Flatiron Health is an oncology-specific health technology and data platform (now part of Roche) that supports community oncology practices and life sciences partners. It is comparable as an oncology-focused technology and analytics enabler for community practices, overlapping with Atlas's analytics platform layer.

Direct peers

• OneOncology: OneOncology is a national platform partnership for independent community oncology practices that takes on value-based and risk-bearing arrangements with payers, mirroring Atlas's core model of enabling community oncology through contracting, analytics, and capital.
• Thyme Care: Thyme Care is a value-based oncology care navigation and care management company that partners with payers and providers to manage cancer patients across the continuum. It is comparable to Atlas's Extended Care Team and care-coordination platform, though it primarily focuses on navigation rather than embedded clinical teams.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/atlas-oncology-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlas Oncology Partners